EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Non-motor symptoms in motor neuron disease: prevalence, assessment and impact

Emily Beswick iD, Deborah Forbes iD, Micheala Johnson, Judith Newton, Rachel Dakin iD, Stella Glasmcher, Sharon Abrahams, Alan Carson, Siddharthan Chandran, Suvankar Pal iD

Brain Communications · 28.12.2023 · 6 (1)

DOI: 10.1093/braincomms/fcad336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Communications, online erschienen am 07.12.2023. Verfasst von Emily Beswick und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Clinical Brain Sciences, the University of Edinburgh, Edinburgh, UK. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Euan Macdonald Centre, Motor Neuron Disease Research and the Anne Rowling Regenerative Neurology Clinic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

People with motor neuron disease often experience non-motor symptoms that may occur secondary to, or distinct from, motor degeneration and that may significantly reduce quality of life, despite being under-recognized and evaluated in clinical practice. Non-motor symptoms explored in this population-based study include pain, fatigue, gastrointestinal issues, poor sleep, low mood, anxiety, problematic saliva, apathy, emotional lability, cognitive complaints and sexual dysfunction. People registered on the Clinical Audit Research and Evaluation of motor neuron disease platform, the Scottish Motor Neuron Disease Register, were invited to complete a questionnaire on non-motor symptoms and a self-reported Amyotrophic Lateral Sclerosis Functional Rating Scale. The questionnaire comprised a pre-defined list of 11 potential non-motor symptoms, with the opportunity to list additional symptoms. A total of 120 individuals participated in this cross-sectional study, a 39% response rate of those sent questionnaires (n = 311); 99% of participants recruited (n = 120) experienced at least one non-motor symptom, with 72% (n = 120) reporting five or more. The symptoms most often reported were pain and fatigue (reported by 76% of participants, respectively). The symptoms reported to be most impactful were gastrointestinal issues (reported as ‘severe’ by 54% of participants who experienced them), followed by pain and problematic saliva (51%, respectively). Lower Amyotrophic Lateral Sclerosis Functional Rating Scale scores, indicating more advanced disease and being a long survivor [diagnosed over 8 years ago; Black et al. (Genetic epidemiology of motor neuron disease-associated variants in the Scottish population. Neurobiol Aging. 2017;51:178.e11-178.e20.)], were significantly associated with reporting more symptoms; 73% of respondents were satisfied with the frequency that non-motor symptoms were discussed in clinical care; 80% of participants indicated they believe evaluation of non-motor symptom is important to include as outcomes in trials, independent of their personal experience of these symptoms. The preferred method of assessment was completing questionnaires, at home. The overwhelming majority of people with motor neuron disease report non-motor symptoms and these frequently co-occur. Pain, fatigue, gastrointestinal issues, sleep, mood, anxiety, problematic saliva, apathy, emotional lability, cognitive complaints and sexual dysfunction are prevalent. People with motor neuron disease who had worse physical function and those who were long survivors were more likely to report more symptoms. Where reported, these symptoms are frequent, impactful and a priority for people with motor neuron disease in clinical care and trial design.

Schlagwörter

Stichwörter der Autor:innen

impactmotor neuron diseasenon-motor symptomsprevalencesurvey

Autor:innen und Institutionen

  • Centre for Clinical Brain Sciences, the University of Edinburgh, Edinburgh, UK.
  • Anne Rowling Regenerative Neurology Clinic, the University of Edinburgh, Edinburgh, UK.
  • Euan MacDonald Centre for MND Research, the University of Edinburgh, Edinburgh, UK.
  • Human Cognitive Neurosciences, Psychology, School of Philosophy, Psychology and Language Sciences, the University of Edinburgh, Edinburgh, EH16 4SB, UK.
  • UK Dementia Research Institute, the University of Edinburgh, Edinburgh, EH16 4SB, UK.

ORCID-Profile: Emily Beswick, Deborah Forbes, Rachel Dakin, Suvankar Pal

Förderung

  • Euan Macdonald Centre
  • Motor Neuron Disease Research and the Anne Rowling Regenerative Neurology Clinic

Zitieren

APA

Beswick, E., Forbes, D., Johnson, M., Newton, J., Dakin, R., Glasmcher, S., Abrahams, S., Carson, A., Chandran, S., & Pal, S. (2023). Non-motor symptoms in motor neuron disease: prevalence, assessment and impact. Brain Communications, 6(1). https://doi.org/10.1093/braincomms/fcad336

Vancouver

Beswick E, Forbes D, Johnson M, Newton J, Dakin R, Glasmcher S, et al. Non-motor symptoms in motor neuron disease: prevalence, assessment and impact. Brain Communications. 2023;6(1). doi:10.1093/braincomms/fcad336

BibTeX
@article{Beswick2023,
  author = {Beswick, Emily and Forbes, Deborah and Johnson, Micheala and Newton, Judith and Dakin, Rachel and Glasmcher, Stella and Abrahams, Sharon and Carson, Alan and Chandran, Siddharthan and Pal, Suvankar},
  title = {Non-motor symptoms in motor neuron disease: prevalence, assessment and impact},
  journal = {Brain Communications},
  year = {2023},
  volume = {6},
  number = {1},
  doi = {10.1093/braincomms/fcad336}
}
Kostenlos starten →